AC Immune SA (ACIU) stock
ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.13−0.01 (-0.47%)
Close on Nov 13, 2026Market cap $216.71MP/E –Yield –
AC Immune total assets
Total assets on the balance sheet at the end of each period.
AC Immune's total assets was CHF 150.40M at Jun 30, 2026. For fiscal 2025 it was CHF 154.25M, down 33.2% from the year before. The highest annual figure on record is CHF 299.25M in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CHF 154.25M | -33.2% |
| FY2024 | Dec 31, 2024 | CHF 230.91M | +26.3% |
| FY2023 | Dec 31, 2023 | CHF 182.81M | -1.7% |
| FY2022 | Dec 31, 2022 | CHF 185.94M | -28.9% |
| FY2021 | Dec 31, 2021 | CHF 261.44M | +9.5% |
| FY2020 | Dec 31, 2020 | CHF 238.74M | -20.2% |
| FY2019 | Dec 31, 2019 | CHF 299.25M | +52.2% |
| FY2018 | Dec 31, 2018 | CHF 196.56M | +48.9% |
| FY2017 | Dec 31, 2017 | CHF 132.01M | -15.4% |
| FY2016 | Dec 31, 2016 | CHF 156.10M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | CHF 150.40M | -36.7% |
| Q4 FY2025 | Dec 31, 2025 | CHF 154.25M | -15.6% |
| Q2 FY2025 | Jun 30, 2025 | CHF 190.22M | +21.8% |
| Q4 FY2024 | Dec 31, 2024 | CHF 230.91M | +24.2% |
| Q2 FY2024 | Jun 30, 2024 | CHF 237.54M | +15.6% |
| Q4 FY2023 | Dec 31, 2023 | CHF 182.81M | -30.1% |
| Q2 FY2023 | Jun 30, 2023 | CHF 156.23M | -34.6% |
| Q4 FY2022 | Dec 31, 2022 | CHF 185.94M | -37.9% |
| Q3 FY2022 | Sep 30, 2022 | CHF 205.56M | +4.6% |
| Q4 FY2021 | Dec 31, 2021 | CHF 261.44M | +98.0% |
| Q4 FY2020 | Dec 31, 2020 | CHF 238.74M | +52.9% |
| Q4 FY2019 | Dec 31, 2019 | CHF 299.25M | – |
| Q4 FY2018 | Dec 31, 2018 | CHF 196.56M | – |
| Q4 FY2017 | Dec 31, 2017 | CHF 132.01M | – |
| Q4 FY2016 | Dec 31, 2016 | CHF 156.10M | – |
See a number that looks wrong?